Anixa Biosciences has authorized a share repurchase program of up to $5M of the company’s outstanding common stock. The repurchase program expires in twelve months and can be suspended or discontinued at any time. No shares have been repurchased under the program to date.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANIX:
Questions or Comments about the article? Write to editor@tipranks.com